Targets, Tracers and Translation - Novel Radiopharmaceuticals Boost Nuclear Medicine
Material type:
ArticleLanguage: English Publication details: MDPI - Multidisciplinary Digital Publishing Institute 2019Description: 1 electronic resource (214 p.)ISBN: - books978-3-03921-314-6
- 9783039213139
- 9783039213146
- n/a
- pretargeting
- radioiodination
- neurodegeneration
- phosphoramidon
- GRPR
- molecular imaging
- allosteric modulator
- radiosynthesis
- separation
- ?-CIT
- PET/CT imaging
- technetium-99m
- gastrin-releasing peptide receptor
- metabotropic glutamate receptor subtype 5
- glutamate
- oncogenic fusions
- Fusarinine C
- hypoxia
- tirapazamine (TPZ)
- 68Ga
- sentinel lymph node
- 99mTc-radioligand
- iodine-131
- electrophilic radioiodination
- 4-dioxide (BTDO)
- minigastrin
- ceftriaxone
- tropomyosin receptor kinase
- carbonic anhydrase IX
- ABP688
- NPY(Y1)R
- MMPEP
- radiosensitizer
- neprilysin-inhibition
- radiochemistry
- girentuximab
- benzotriazine-1
- gallium-68
- cholecystokinin-2 receptor
- tumor targeting
- radioimmunotherapy
- salivary gland uptake
- metabolic stability
- tumor hypoxia
- multimerization
- oxidizing agent
- neuroinflammation
- gastrin-releasing peptide
- dextran
- carbon-11
- peptide heterodimers
- apparent molar activity
- radiometals
- microglia
- rituximab
- [18F]FMISO
- [11C]meta-hydroxyephedrine
- Iodo-Gen®
- mannose
- 177Lu-radiopharmaceuticals
- azomycin nucleosides
- breast cancer
- click chemistry
- small animal imaging
- SR 4317
- benzotriazine-1-monoxide (BTMO)
- bombesin
- prostate cancer
- Chloramine T
- 99mTc-radiopharmaceuticals
- ketamine
- PSMA-617
- positron emission tomography
- hydrazinonicotinic acid (HYNIC)
- renal cell carcinomas
- [18F]PSS232
- PET
- endoradiotherapy
| Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|
Electronic-Books
|
OPJGU Sonepat- Campus | E-Books Open Access | Available |
Open Access star Unrestricted online access
This is the fourth Special Issue in Pharmaceuticals within the last six years dealing with aspects of radiopharmaceutical sciences. It demonstrates the significant interest and increasing relevance to ameliorate nuclear medicine imaging with PET or SPECT, and also radiotherapeutical procedures.Numerous targets and mechanisms have been identified and have been under investigation over the previous years, covering many fields of medical and clinical research. This development is well illustrated by the articles in the present issue, including 13 original research papers and one review, covering a broad range of actual research topics in the field of radiopharmaceutical sciences.
Creative Commons https://creativecommons.org/licenses/by-nc-nd/4.0/ cc https://creativecommons.org/licenses/by-nc-nd/4.0/
English
There are no comments on this title.